PK/PD Study of Escalating Dose D-Serine as Adjunctive Treatment in Schizophrenia.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs D-serine (Primary)
- Indications Schizophrenia
- Focus Therapeutic Use
- 05 Oct 2020 Biomarkers information updated
- 28 Oct 2008 Status changed from recruiting to active, no longer recruiting.
- 29 Feb 2008 Planned end date (Jun 2008) added as reported by ClinicalTrials.gov.